您现在的位置: 首页> 研究主题> 局部缺血

局部缺血

局部缺血的相关文献在1986年到2022年内共计554篇,主要集中在外科学、基础医学、内科学 等领域,其中期刊论文456篇、会议论文12篇、专利文献33984篇;相关期刊204种,包括中国组织化学与细胞化学杂志、中国病理生理杂志、医学临床研究等; 相关会议8种,包括第七届国际血管外科及腔内血管外科学术会议、第三届全国口腔颌面修复重建外科学术会议、第三届“全国再生医学(干细胞与组织工程)学术研讨会”第二届“血管外科与组织工程专题研讨会”等;局部缺血的相关文献由1470位作者贡献,包括李建生、赵君玫、郭盛典等。

局部缺血—发文量

期刊论文>

论文:456 占比:1.32%

会议论文>

论文:12 占比:0.03%

专利文献>

论文:33984 占比:98.64%

总计:34452篇

局部缺血—发文趋势图

局部缺血

-研究学者

  • 李建生
  • 赵君玫
  • 郭盛典
  • 李建国
  • ChenliLi
  • 俞恒锡
  • 崔世军
  • 张建
  • 谷涌泉
  • YuZhao
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 黄坤; 陈真; 杨莉; 景蓉; 张贝贝
    • 摘要: 上肢功能障碍是脑卒中患者常见的一种后遗症,脑组织局部缺血是主要的导致原因。手、上肢的功能较为复杂、精细,常规康复治疗恢复较慢,且会降低患者的生活质量。因此针对此类患者需要给予多种技术以及多个领域的共同协作治疗。相关研究指出,运动想象(MI)疗法有利于脑卒中上肢功能障碍患者的功能恢复,其是依据经常在大脑中浮现的运动记忆对指定的身体部位进行刺激,以此改善患者的运动功能,且不会增加发生不良反应的概率,操作简单,费用较低[1]。本文主要分析脑卒中上肢功能障碍患者应用MI疗法的效果,报告如下。
    • 王兴辕; 夏讯
    • 摘要: 脑梗死属又称缺血性卒中,为临床常见的脑卒中类型,以老年人群多发。脑梗死后偏瘫是其致残的主要原因之一,以偏身感觉及运动障碍为主要临床表现,严重影响患者的生活质量和生命安全[1]。该病患者因脑组织局部缺血、缺氧,致使神经元凋亡坏死而产生神经功能缺损,进而致使患者肢体功能出现不同程度的功能障碍[2]。因此改善患者神经功能,对控制患者病情进展及提高其生活质量具有重要影响。
    • 李莹; 张翠翠; 车晓囡; 刘晓
    • 摘要: 一般情况下,肾脏可以通过自我调节机制及机能性代偿的方式调动肾脏储备,缓解部分肾单位的损伤所造成的肾脏功能降低,来维持个体正常的生理状态,这也是早期的慢性肾病不易被萌宠主人察觉的原因。但当双侧肾脏接近75%的肾单位因不同程度损伤而丧失功能时,就会发生肾衰竭[1-2]。急性肾衰竭(ARF)通常是由于肾脏局部缺血或者毒物造成的损伤,一般情况下,所引起的肾脏损伤及机能异常可能是可逆的,而慢性肾衰竭的是不可逆的。
    • 魏亚丰1
    • 摘要: 以往很多人认为只有大脑能中风(卒中),其实,动脉粥样硬化是一种全身性疾病。凡是有动脉血管的地方,几乎都可能由于局部缺血而出现中风,比如肠中风、眼中风等,这些问题如果不及时治疗,也可能引发严重的不良后果。
    • 张世卿; 张磊; 张国清
    • 摘要: Objective To investigate the effect of Anti TNF-α combined with p38 MAPK antisense oligonucleotide on renal funtion and TNF-α,p38MAPK protein expression at different ischemia-reperfusion points.Methods One hundred and twenty normal male Sprague-Dawley rats were divided into 4 groups by simple randomization:sham-operated (sham) group,ischemia-reperfusion (IR) group,Anti TNF-α + ischemia-reperfusion (Anti TNF-α + IR) group,Anti TNF-α and p38 MAPK antisense oligonucleotide + ischemia-reperfusion (combination preconditioning + IR) group.Each group comprised 30 rats.Anti TNF-α + IR group was subjected to ischemia-reperfusion injury with intravenous administration of Anti TNF-α (0.1 mg/kg) 5 min before reperfusion.Combination preconditioning + IR group was subjected to ischemia-reperfusion injury with intravenous administration of Anti TNF-α(0.1 mg/kg)and p38MAPK antisense oligonucleotide (5 mg/kg)5 min before reperfusion.IR group with the same injury was followed by saline administration in the same manner.Sham group was subjected to only anesthetization but not to ischemia.Detecting the plasma creatinine and plasma urea nitrogen and two-step inmunohistochemical methods were used to detect the changes of expression of TNF-α,p38 MAPK.The measurement data were compared with the t test and the count data were compared with Chi-square test.The date were expressed by ((x) ± s).Intergroup comparison translated by variance analysis.Results After reperfusion,the plasma urea nitrogen in the IR group was (15.86 ± 2.41),(21.13 ± 2.21),(25.47 ± 2.29),(30.51 ± 2.03),(35.56±2.47) μmol/L at 0,1,3,6 and 12 h,respectively,and was (25.61 ±5.40),(32.48 ±2.30) (68.20±1.20),(84.42 ±2.43),(96.15 ±2.23)at 0,1,3,6 and 12 h respectively,and still showed an increasing trend at 12 h.TNF-α mainly expressed in renal proximal convoluted tubules,gradually upregulate with duration of ischemia-reperfusion to 12h of reperfusion.p38MAPK mainly located at distal convoluted tubules,peaked at 6h of reperfusion.But these effects were offset by administration in combination preconditioning group (P < 0.05).Conclusion Renal ischemia-reperfusion injury can be alleviated by Anti TNF-α and p38 MAPK antisense oligonucleotide treatment.%目的 探讨抗肿瘤坏死因子-α(TNF-α)单抗联合p38丝裂原活化蛋白激酶(p38 MAPK)反义寡核苷酸预处理对缺血再灌注肾不同时间肾功能的变化和TNF-α、p38MAPK蛋白表达的影响.方法 健康雄性SD大鼠120只,按简单随机化分成4组,假手术(Sham)组、缺血再灌注(IR)组、抗TNF-α单抗+缺血再灌注(抗TNF-α单抗+IR)组、抗TNF-α单抗联合p38 MAPK反义寡核苷酸+缺血再灌注(联合预处理+IR)组.每组30只.假手术组于麻醉后分离肾动脉但不夹闭.抗TNF-α单抗+IR组于恢复血供前5 min通过尾静脉注入抗TNF-α单抗(0.1 mg/kg,用0.9%氯化钠溶液稀释至0.1 ml).联合预处理组于恢复血供前5 min通过尾静脉注入抗TNF-α单抗(0.1 mg/kg)和p38 MAPK反义寡核苷酸(5 mg/kg两者用0.9%氯化钠溶液稀释至0.1 ml).IR组于恢复血供前5 min通过尾静脉注入0.1ml 0.9%氯化钠溶液.全自动生化分析仪检测血浆尿素氮和肌酐水平,采用免疫组化二步法检测肾组织TNF-α、p38 MAPK蛋白表达.计量资料采用t检验,计数资料采用x2检验,数据以均数±标准差((x)±s)表示,组间比较采用方差分析.结果 IR组于再灌注后血浆尿素氮在0、1、3、6、12 h分别为(15.86±2.41)、(21.13±2.21)、(25.47±2.29)、(30.51±2.03)、(35.56±2.47) μmol/L、肌酐在0、1、3、6、12 h分别为(25.61±5.40)、(32.48 ±2.30)、(68.20±1.20)、(84.42±2.43)、(96.15±2.23) μmol/L,至12h仍呈升高趋势.联合预处理组再灌注后血浆尿素氮、肌酐上升幅度低于缺血再灌注组相应时间点(P<0.05).TNF-α蛋白在近端小管上皮细胞表达为著,随着再灌注时间延长的明显增加,再灌注12h时仍呈增高趋势.p38MAPK主要在远端小管上皮细胞表达,再灌注后6h后达高峰.联合预处理组TNF-α、p38MAPK蛋白水平显著低于IR组(P<0.05).结论 抗TNF-α单抗及p38MAPK反义寡核苷酸联合应用,通过降低TNF-α、p38MAPK蛋白表达水平,减轻肾缺血再灌注损伤.
    • Hiroyuki Horiguehi1; Philip A. Efron1; 肖薇薇2
    • 摘要: 春季随着四月悄然而至,本期的Shock也带来了另外一系列优秀的文章,内容涵盖了包括创伤,脓毒症,炎症,局部缺血和再灌注及其他休克相关的所有领域。包括了三篇综述,五篇临床研究和六篇基础科学研究。文章源于世界上一些最好的实验室,且呈现了由基础到临床科学类别各方面的多种多样。这些文章代表了Shock期刊的影响并且将继续扩大其影响。
    • Chie Takasu; Nosratola D Vaziri; Shiri Li; Lourdes Robles; Kelly Vo; Mizuki Takasu; Christine Pham; Seyed H Farzaneh; Mitsuo Shimada; Michael J Stamos; Hirohito Ichii
    • 摘要: AIM To investigate the hypothesis that treatment with dimethyl fumarate(D MF) mayame liorate liver ischemia/reperfusion injury(I/RI).METHODS Rats were divided into 3 groups: sham, control(CTL), and DMF. DMF(25 mg/kg, twice/d) was orally administered for 2 d before the procedure. The CTL and DMF rats were subjected to ischemia for 1 h and reperfusion for 2 h. The serum alanine aminotransferase(ALT) and malondialdehyde(MDA) levels, adenosine triphosphate(ATP), NO × metabolites, anti-oxidant enzyme expression level, antiinflammatory effect, and anti-apoptotic effect were determined.RESULTS Histological tissue damage was significantly reduced in the DMF group(Suzuki scores: sham: 0 ± 0; CTL: 9.3± 0.5; DMF: 2.5 ± 1.2; sham vs CTL, P < 0.0001; CTL vs DMF, P < 0.0001). This effect was associated with significantly lower serum ALT(DMF 5026 ± 2305 U/L vs CTL 10592 ± 1152 U/L, P = 0.04) and MDA(DMF 18.2 ± 1.4 μmol/L vs CTL 26.0 ± 1.0 μmol/L, P = 0.0009). DMF effectively improved the ATP content(DMF 20.3 ± 0.4 nmol/mg vs CTL 18.3 ± 0.6 nmol/mg, P = 0.02), myeloperoxidase activity(DMF 7.8 ± 0.4 m U/m L vs CTL 6.0 ± 0.5 m U/m L, P = 0.01) and level of endothelial nitric oxide synthase expression(DMF 0.38 ± 0.05-fold vs 0.17 ± 0.06-fold, P = 0.02). The higher expression levels of anti-oxidant enzymes(catalase and glutamatecysteine ligase modifier subunit and lower levels of key inflammatory mediators(nuclear factor-kappa B and cyclooxygenase-2 were confirmed in the DMF group.CONCLUSION DMF improved the liver function and the anti-oxidant and inflammation status following I/RI. Treatment with DMF could be a promising strategy in patients with liver I/RI.
    • 于倩; 冯坤丽; 黄建军
    • 摘要: Objective:To assess the diagnostic value by measuring the level of serum ischemia modified albumin ( IMA) in early diagnosis of patients with acute myocardial ischemia(ACS) and acute ischemic stroke(AIS).Methods:The whole blood samples were collected from the ACS and AIS patients(n=50) admitted to the Emergency Department of our hospital between September 2013 and November 2014,and health subjects(n=50).Then the partici-pants were allocated to ACS group,AIS group and control group,and serum IMA levels were measure.Results:The serum IMA concentration was (88.3 ± 10.2)U/mL and (92.6 ±10.4)U/mL for ACS and AIS patients,which was higher than the healthy controls(71.6 ±9.8) U/mL,P0.05),and IMA sensitivity and specificity were 86% and 92% in ACS group compared to 88% and 94% in AIS group.Conclusion:The serum IMA level may be a useful indicator in diagnosis of patients with acute myo-cardial ischemia and acute ischemic stroke.%目的:探讨外周血缺血修饰性白蛋白(ischemia-modified albumin,IMA)水平在急性冠脉综合征(acute coronary syn-drome,ACS)和急性缺血性脑卒中( acute ischemic stroke,AIS)中的诊断价值。方法:收集2013年9月~2014年11月皖南医学院附属弋矶山医院急诊科收治的ACS和AIS患者及健康体检者全血标本,分为ACS组、AIS组和对照组,每组收集满50例为止。检测血清中IMA浓度。结果:IMA在ACS组和AIS组患者中的水平分别为(88.3±10.2) U/mL和(92.6±10.4) U/mL,显著高于对照组(71.6±9.8)U/mL(P<0.001)。 ACS组和AIS组患者中IMA的水平与肌钙蛋白Ⅰ(Trop Ⅰ)水平间的关联无统计学差异(两组均为P>0.05)。 IMA灵敏度在ACS组和AIS组中分别为86%和88%,特异性分别为92%和94%。结论:由诊断界值确定的灵敏度和特异度表明,IMA是ACS患者和AIS患者诊断的有益指标。
    • 本刊
    • 摘要: 磁共振功能成像可检测组织坏死、局部缺血及各种病变,分辨率较高,有利于对疾病早期诊断。目前临床使用的磁共振造影剂大都为小分子,采用纳米材料作为载体来装载造影剂以提高生物组织局部的造影剂浓度。
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号